We are live on ! Find out more
DG

Daventry Group Portfolio holdings

AUM $87.8M
1-Year Est. Return 3.83%
This Fund
S&P 500
This Quarter Est. Return
+15.79%
1 Year Est. Return
-3.83%
3 Year Est. Return
-12.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$143M
AUM Growth
+$27.1M
Cap. Flow
+$11M
Cap. Flow %
7.68%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
6
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$14.3M
2
ESTC icon
Elastic
ESTC
+$3.89M
3
EVBG
Everbridge, Inc. Common Stock
EVBG
+$3.44M
4
HCAT icon
Health Catalyst
HCAT
+$2.52M
5
NEWR
New Relic, Inc.
NEWR
+$1.95M

Top Sells

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$18M

Sector Composition

Rank Sector Weight
1 Technology 62.68%
2 Healthcare 22.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TENB icon
1
Tenable Holdings
TENB
$3.76B
$29.1M 20.36%
612,433
+38,979
+7% +$1.66M
NEWR
2
DELISTED
New Relic, Inc.
NEWR
$21.5M 15.05%
285,646
+28,919
+11% +$1.95M
ESTC icon
3
Elastic
ESTC
$6.26B
$21.2M 14.81%
365,725
+68,188
+23% +$3.89M
PTC icon
4
PTC
PTC
$13.9B
$19.9M 13.95%
155,552
+9,875
+7% +$1.26M
EVBG
5
DELISTED
Everbridge, Inc. Common Stock
EVBG
$19.4M 13.55%
558,678
+107,530
+24% +$3.44M
HCAT icon
6
Health Catalyst
HCAT
$155M
$19.1M 13.37%
1,637,111
+197,497
+14% +$2.52M
CRL icon
7
Charles River Laboratories
CRL
$10.6B
$12.7M 8.91%
+63,123
New +$14.3M
OSH
8
DELISTED
Oak Street Health, Inc.
OSH
– –
-838,577
Closed -$18M

Similar funds

XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
EFA
Englebert Financial Advisers Allentown, Pennsylvania $87.9M AUM
BCP
Balance Capital Partners New York $87.9M AUM
PM
Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $88M AUM
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return

Daventry Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daventry Group held 8 positions worth $143M, up 23% from $116M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Daventry Group deployed $11M of net new capital in Q1 2023, opening 1 new position and adding to 6 existing holdings. Its largest new stake was Charles River Laboratories: 63,123 shares worth $12.7M.

By sector, the portfolio is most concentrated in Technology at 63% of assets, up from 59% a quarter earlier, followed by Healthcare.

On the sell side, the most notable exit was Oak Street Health, Inc., an estimated $18M sold.

  • Daventry Group's largest Q1 2023 buy was Charles River Laboratories: 63,123 shares worth $12.7M.
  • Daventry Group added most to Elastic in Q1 2023, an estimated $3.89M increase.
  • Daventry Group fully exited Oak Street Health, Inc. in Q1 2023, selling an estimated $18M.
  • Daventry Group's ten largest holdings make up 100% of its $143M portfolio in Q1 2023.
  • Daventry Group opened 1 new position and closed 1 in Q1 2023.
  • Daventry Group's portfolio value rose 23% quarter-over-quarter to $143M.

Based on Daventry Group's 13F filing for Q1 2023, filed 12 May 2023.